Further studies showed that S1P/S1pr1 praxis activated AKT/eNOS signalling pathways and enhanced the production of NO, which contributed to the protective effect of EC‐S1pr1 on cardiac hypertrophy and fibrosis. The gene discussed is S1PR1; the disease is cardiac hypertrophy.